Zyla Life Sciences   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Vaerlose Denmark (1995)
Status: Acquired by Assertio (2020)

Organization Overview

First Clinical Trial
2002
NCT01356212
First Marketed Drug
1995
indomethacin (indocin)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

EGALET | Egalet Ltd | ZYLA